Showing results (201-210 of 415) with videos related to
Sort By:
Pageof 42
Physical Chemistry Chemical Physics : PCCP|February 17, 2006
The chiroptical signature of achiral metal clusters induced by dissymmetric adsorbatesMichael-Rock Goldsmith, Christopher B George, Gérard Zuber, et al.Current Topics in Medicinal Chemistry|October 8, 2009
A case study from the chemistry core of the Pittsburgh Molecular Library Screening Center: the Polo-like kinase polo-box domain (Plk1-PBD)Peter Wipf, David Arnold, Karen Carter, et al.Journal of the American Chemical Society|September 8, 2005
Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugatesPeter Wipf, Jingbo Xiao, Jianfei Jiang, et al.Organic Letters|March 31, 2007
Origins of the high 14-helix propensity of cyclohexyl-rigidified residues in beta-peptidesMyung-Ryul Lee, Tami L Raguse, Marina Schinnerl, et al.Elife|June 28, 2021
Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromisedSara Sannino, Megan E Yates, Mark E Schurdak, et al.Biochemical Pharmacology|April 28, 2023
Quassinoid analogs exert potent antitumor activity via reversible protein biosynthesis inhibition in human colorectal cancerNing Wei, James Burnett, Desirae L Crocker, et al.Journal of Clinical Medicine|September 27, 2025
Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular TherapeuticKeertana Yalamanchili, Mark Broadwin, Dwight D Harris, et al.The Prostate|December 24, 2019
A novel androgen receptor antagonist JJ-450 inhibits enzalutamide-resistant mutant ARF876L nuclear import and functionZeyu Wu, Ke Wang, Zhenyu Yang, et al.Molecular Cancer Therapeutics|February 5, 2008
A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cellsAndreas Vogt, Peter R McDonald, Aletheia Tamewitz, et al.Molecular Cancer Therapeutics|January 14, 2009
Peroxisome proliferator-activated receptor gamma agonist pioglitazone prevents the hyperglycemia caused by phosphatidylinositol 3-kinase pathway inhibition by PX-866 without affecting antitumor activityNathan T Ihle, Robert Lemos, David Schwartz, et al.Pageof 42